The Mary Miller Amendment would result in federal prohibition of 90-95% of all hemp products on the market, even many CBD products that naturally contain trace, non-intoxicating amounts of THC.

A coalition of hemp industry companies and associations agrees: "We need FDA action to regulate hemp products, and we need it now."

As negotiations for the next U.S. Farm Bill commence, a united hemp industry has come together to advocate for the inclusion of seven critical objectives.

NPA, CRN, & the U.S. Hemp Roundtable were among those to offer testimony at the Congressional hearing "Hemp in the Modern World: The Years long Wait for FDA Action."

A bill to establish a framework for the FDA to regulate hemp-derived CBD as a dietary supplement or food and beverage additive has been reintroduced, and Congress is formally scrutinizing FDA's inaction on hemp products such as CBD.